133 related articles for article (PubMed ID: 10092592)
1. Acrolein causes inhibitor kappaB-independent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells.
Horton ND; Biswal SS; Corrigan LL; Bratta J; Kehrer JP
J Biol Chem; 1999 Apr; 274(14):9200-6. PubMed ID: 10092592
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications.
Biswal S; Acquaah-Mensah G; Datta K; Wu X; Kehrer JP
Chem Res Toxicol; 2002 Feb; 15(2):180-6. PubMed ID: 11849044
[TBL] [Abstract][Full Text] [Related]
3. Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein.
Horton ND; Mamiya BM; Kehrer JP
Toxicology; 1997 Sep; 122(1-2):111-22. PubMed ID: 9274807
[TBL] [Abstract][Full Text] [Related]
4. Effect of acrolein and glutathione depleting agents on thioredoxin.
Yang X; Wu X; Choi YE; Kern JC; Kehrer JP
Toxicology; 2004 Nov; 204(2-3):209-18. PubMed ID: 15388247
[TBL] [Abstract][Full Text] [Related]
5. Effect of acrolein on human alveolar macrophage NF-kappaB activity.
Li L; Hamilton RF; Holian A
Am J Physiol; 1999 Sep; 277(3):L550-7. PubMed ID: 10484462
[TBL] [Abstract][Full Text] [Related]
6. Conjugated polyhydroxybenzene derivatives block tumor necrosis factor-alpha-mediated nuclear factor-kappaB activation and cyclooxygenase-2 gene transcription by targeting IkappaB kinase activity.
Chen CC; Chiu KT; Chan ST; Chern JW
Mol Pharmacol; 2001 Dec; 60(6):1439-48. PubMed ID: 11723253
[TBL] [Abstract][Full Text] [Related]
7. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells.
Vertegaal AC; Kuiperij HB; Yamaoka S; Courtois G; van der Eb AJ; Zantema A
Cell Signal; 2000 Dec; 12(11-12):759-68. PubMed ID: 11152962
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
10. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of TNFalpha cytotoxicity: activation of NF-kappaB and nuclear translocation.
Claudio E; Segade F; Wrobel K; Ramos S; Bravo R; Lazo PS
Exp Cell Res; 1996 Apr; 224(1):63-71. PubMed ID: 8612692
[TBL] [Abstract][Full Text] [Related]
12. Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein.
Biswal S; Maxwell T; Rangasamy T; Kehrer JP
Carcinogenesis; 2003 Aug; 24(8):1401-6. PubMed ID: 12807757
[TBL] [Abstract][Full Text] [Related]
13. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
McDade TP; Perugini RA; Vittimberga FJ; Carrigan RC; Callery MP
J Surg Res; 1999 May; 83(1):56-61. PubMed ID: 10210643
[TBL] [Abstract][Full Text] [Related]
14. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation.
Alpert D; Schwenger P; Han J; Vilcek J
J Biol Chem; 1999 Aug; 274(32):22176-83. PubMed ID: 10428782
[TBL] [Abstract][Full Text] [Related]
15. Activation of NF-kappaB by PM(10) occurs via an iron-mediated mechanism in the absence of IkappaB degradation.
Jiménez LA; Thompson J; Brown DA; Rahman I; Antonicelli F; Duffin R; Drost EM; Hay RT; Donaldson K; MacNee W
Toxicol Appl Pharmacol; 2000 Jul; 166(2):101-10. PubMed ID: 10896851
[TBL] [Abstract][Full Text] [Related]
16. Taxol selectively blocks microtubule dependent NF-kappaB activation by phorbol ester via inhibition of IkappaBalpha phosphorylation and degradation.
Spencer W; Kwon H; Crépieux P; Leclerc N; Lin R; Hiscott J
Oncogene; 1999 Jan; 18(2):495-505. PubMed ID: 9927206
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion inhibits lipopolysaccharide-induced intercellular adhesion molecule 1 synthesis.
Szászi K; Jones JJ; Nathens AB; Lo AY; Marsden PA; Kapus A; Rotstein OD
Free Radic Biol Med; 2005 May; 38(10):1333-43. PubMed ID: 15855051
[TBL] [Abstract][Full Text] [Related]
18. Hyperoxia prolongs tumor necrosis factor-alpha-mediated activation of NF-kappaB: role of IkappaB kinase.
Wong HR; Odoms KK; Denenberg AG; Allen GL; Shanley TP
Shock; 2002 Apr; 17(4):274-9. PubMed ID: 11954826
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2.
Anto RJ; Mukhopadhyay A; Shishodia S; Gairola CG; Aggarwal BB
Carcinogenesis; 2002 Sep; 23(9):1511-8. PubMed ID: 12189195
[TBL] [Abstract][Full Text] [Related]
20. Acrolein, an I-κBα-independent downregulator of NF-κB activity, causes the decrease in nitric oxide production in human malignant keratinocytes.
Moon KY
Arch Toxicol; 2011 May; 85(5):499-504. PubMed ID: 20890592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
